We have a high flyer joining Quetzal (QTZ) to start the week, as it announced the appointment of Tony Quirke as a Non-executive Director with immediate effect.
We have a high flyer joining Quetzal (QTZ) to start the week, as it announced the appointment of Tony Quirke as a Non-executive Director with immediate effect.
Introduction: At the time of writing the US stock market is set for its 70th record close of the year. Older market watchers will know that a wall of worry is what
Introduction: At the time of writing the US stock market is set for its 70th record close of the year. Older market watchers will know that a wall of worry is what
The Top 20 For 2022:Â Of course, at this time of the year, everyone and their mother deliver their list for the winners of the New Year, as I have in
The Top 20 For 2022:Â Of course, at this time of the year, everyone and their mother deliver their list for the winners of the New Year, as I have in
The Top 20 For 2022: Of course, at this time of the year, everyone and their mother deliver their list for the winners of the New Year, as I have
Zak Mir looks at some of the most followed small caps in London from a technical perspective. Today’s selection includes Contango, Eurasia, Genedrive, Galileo, Ilika, Napster, Oxford Biodynamics, Pensana, Proton,
Introduction: At the time of writing the US stock market is set for its 70th record close of the year. Older market watchers will know that a wall of worry is
Zak Mir takes a technical perspective on some of the most followed small caps on the London market. Today’s selection includes Blue, Challenger, Eve, Feedback, Hemo, Live, Midatech, MyHealth, Nanosynth,
With a mention in the Sunday Express yesterday helping along, OKYO Pharma (OKYO), a biotechnology company announced that its drug candidate OK-101 which was developed to treat DED through its
£1,500,000 convertible loan investment into TAP Global Limited Regulated Crypto Exchange Quetzal Call Option to acquire 100% of TAP Global Limited